WebJan 29, 2024 · This is an open label pilot trial in which 25 people with ALS will take clenbuterol orally at 40-80 micrograms twice daily for 24 weeks. ... Duke University: ClinicalTrials.gov Identifier: NCT04245709 Other Study ID Numbers: ... Motor Neuron Disease Amyotrophic Lateral Sclerosis Sclerosis Pathologic Processes … WebConnecting ALS Podcast; Research; ... Duke University ALS Center. 932 Morreene Rd. Durham, NC 27705 United States. Medical Director. Richard S. Bedlack, M.D., Ph.D. For more information, contact: 919-668-2875 - Fax: 919-668-2901. Visit our website for more information. ALS Assocation. Our mission is to discover treatments and a cure for ALS ...
Richard Stanley Bedlack Scholars@Duke - Duke …
WebDuke ALS Clinic multi-disciplinary team identifies specific ALS symptoms and problems and provides a wide range of options for dealing with them. Our Clinic History and Evolution … WebThe ALS Therapy Development Institute maintains a comprehensive and unbiased database of ALS clinical trials. Search our database find information on all those enrolling worldwide. ... Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) Phase 3 - … sacat hearing outcomes
Clinical Trials at Duke Duke Health
WebPlease note that this is a partial list of clinical trials available at Duke. New trials are added to the site regularly. You may find additional clinical trials at Duke by searching clinicaltrials.gov. Questions? Contact the Duke Recruitment Innovation Center at [email protected] or 919-681-5698 . WebJun 3, 2024 · Duke's ALS Center is one of approximately 100 centers in the world dedicated to the diagnosis and treatment of amyotrophic lateral sclerosis (ALS), also known as Lou … WebNov 16, 2024 · Led by three families who mobilized their personal networks and ultimately generated support from more than 500 donors, the Duke ALS community raised $3.5 million to establish the Stewart, Hughes, … sacat hearings